Patients Reuters Pharma USA – Ligia Del Bianco At Reuters Pharma USA last month in Philadelphia, centring the voice of the patient was a major topic of discussion throughout the event.
Events Partner Content 2nd Gene Therapy for Neurological Disorders Europe Maximising the Opportunity in CNS Gene Therapies
News Biogen go quantum to speed up drug development Quantum computing algorithm could lead to new neurological disease drugs.
News Lundbeck enlists IBM Watson to aid psychiatric drug research Collaboration will initially focus on Parkinson's disease and schizophrenia.
News Sanofi draws up $9.1bn plan to buy Blueprint Meds Sanofi has bolstered its rare disease business with an agreement to buy Blueprint Medicines and blockbuster-in-waiting Ayvakit for ASM.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.
